Autonomix secures Canadian patent for catheter-based technologies
October 5, 2026
The newly granted patent protects intraluminal systems and instruments that operate from within a bodily lumen.
The newly granted patent protects intraluminal systems and instruments that operate from within a bodily lumen.
What if checking medication levels were as simple as enjoying a lollipop? A candy-coated device called Lollylab could provide the answer. In ACS Sensors, researchers describe how the lollipop’s stem transfers saliva to a sensor that measures acetaminophen levels.
ABBOTT PARK, Ill., Oct. 5, 2026 /PRNewswire/ — Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) approval for updates to the CardioMEMS HF System that enable new patient-facing capabilities through the CardioGuide HF App.
For millions of people at risk of glaucoma, healthy eye pressure can mean the difference between preserving vision and losing it. Yet despite decades of research, scientists still do not fully understand what regulates daily changes in eye pressure or how those fluctuations may contribute to glaucoma.
A small capsule could change how we study the microbiome of the small intestine. A team led by researchers at the University of Tokyo has created a pill-shaped device designed to take samples from the small intestine using a tiny extendable brush.
Wristband device from Encora Therapeutics started as a project in 2.009, MIT’s iconic product-design class.
Mendaera announced its handheld robot for needle-based procedures is now available to pair with Butterfly Network’s (NYSE:BFLY) portable, chip-based ultrasound probe, following the companies’ long-running collaboration.
A new study led by researchers from the Icahn School of Medicine at Mount Sinai and published in Brain Communications found that a transcranial low-amplitude magnetic field intervention delivered twice weekly into the brain through a noninvasive headset was associated with improvements in several measures of cognitive function and emotional well-being in people experiencing cognitive impairment associated with long COVID.
MARLBOROUGH, Mass., Oct. 1, 2026 /PRNewswire/ — BTL Industries, a global leader in medical and wellness technologies, today announced expanded FDA clearances for EXOMIND®, its noninvasive brain stimulation platform.
Medtronic plans to study the device in patients with peripheral artery disease below the knee, a historically difficult condition to treat.